Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.

Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR.

Gut. 2019 Sep 10. pii: gutjnl-2019-318264. doi: 10.1136/gutjnl-2019-318264. [Epub ahead of print]

2.

TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism.

Bloemendaal FM, Koelink PJ, van Schie KA, Rispens T, Peters CP, Buskens CJ, van der Bilt JD, Bemelman WA, Korf H, Sabino JG, Ponsioen CY, Te Velde AA, D'Haens GRAM, van den Brink GR, Wildenberg ME.

J Crohns Colitis. 2018 May 30. doi: 10.1093/ecco-jcc/jjy075. [Epub ahead of print]

PMID:
29860435
3.

Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease.

Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, van 't Wout AB, Atreya R, Vieth M, Brandse JF, Duijst S, Te Velde AA, D'Haens GRAM, Levesque BG, van den Brink GR.

J Crohns Colitis. 2018 Jun 28;12(7):794-803. doi: 10.1093/ecco-jcc/jjy035.

4.

Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune Response.

Westendorp BF, Büller NVJA, Karpus ON, van Dop WA, Koster J, Versteeg R, Koelink PJ, Snel CY, Meisner S, Roelofs JJTH, Uhmann A, Ver Loren van Themaat E, Heijmans J, Hahn H, Muncan V, Wildenberg ME, van den Brink GR.

Cell Mol Gastroenterol Hepatol. 2017 Sep 5;5(1):67-82.e1. doi: 10.1016/j.jcmgh.2017.08.004. eCollection 2018.

5.

Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and Enhance Therapeutic Efficacy in a Murine Model.

Wildenberg ME, Levin AD, Ceroni A, Guo Z, Koelink PJ, Hakvoort TBM, Westera L, Bloemendaal FM, Brandse JF, Simmons A, D'Haens GR, Ebner D, van den Brink GR.

J Crohns Colitis. 2017 Dec 4;11(12):1480-1490. doi: 10.1093/ecco-jcc/jjx104.

6.

Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.

Bloemendaal FM, Levin AD, Wildenberg ME, Koelink PJ, McRae BL, Salfeld J, Lum J, van der Neut Kolfschoten M, Claassens JW, Visser R, Bentlage A, D'Haens GRAM, Verbeek JS, Vidarsson G, van den Brink GR.

Gastroenterology. 2017 Nov;153(5):1351-1362.e4. doi: 10.1053/j.gastro.2017.07.021. Epub 2017 Jul 27.

PMID:
28756234
7.

The ATG16L1 risk allele associated with Crohn's disease results in a Rac1-dependent defect in dendritic cell migration that is corrected by thiopurines.

Wildenberg ME, Koelink PJ, Diederen K, Te Velde AA, Wolfkamp SC, Nuij VJ, Peppelenbosch MP, Nobis M, Sansom OJ, Anderson KI, van der Woude CJ, D'Haens GR, van den Brink GR.

Mucosal Immunol. 2017 Mar;10(2):352-360. doi: 10.1038/mi.2016.65. Epub 2016 Jul 20.

PMID:
27435106
8.

Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease.

McRae BL, Levin AD, Wildenberg ME, Koelink PJ, Bousquet P, Mikaelian I, Sterman AS, Bryant S, D'Haens G, Kamath R, Salfeld J, van den Brink GR.

J Crohns Colitis. 2016 Jan;10(1):69-76. doi: 10.1093/ecco-jcc/jjv179. Epub 2015 Oct 1.

PMID:
26429698
9.

Autophagy Contributes to the Induction of Anti-TNF Induced Macrophages.

Levin AD, Koelink PJ, Bloemendaal FM, Vos AC, D'Haens GR, van den Brink GR, Wildenberg ME.

J Crohns Colitis. 2016 Mar;10(3):323-9. doi: 10.1093/ecco-jcc/jjv174. Epub 2015 Sep 27.

10.

Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis.

Morgan ME, Koelink PJ, Zheng B, den Brok MH, van de Kant HJ, Verspaget HW, Folkerts G, Adema GJ, Kraneveld AD.

Mucosal Immunol. 2014 Sep;7(5):1266-77. doi: 10.1038/mi.2014.16. Epub 2014 Mar 26.

11.

Deoxynivalenol: a trigger for intestinal integrity breakdown.

Akbari P, Braber S, Gremmels H, Koelink PJ, Verheijden KA, Garssen J, Fink-Gremmels J.

FASEB J. 2014 Jun;28(6):2414-29. doi: 10.1096/fj.13-238717. Epub 2014 Feb 25.

PMID:
24568843
12.

Autistic-like behavioural and neurochemical changes in a mouse model of food allergy.

de Theije CG, Wu J, Koelink PJ, Korte-Bouws GA, Borre Y, Kas MJ, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD.

Behav Brain Res. 2014 Mar 15;261:265-74. doi: 10.1016/j.bbr.2013.12.008. Epub 2013 Dec 12.

PMID:
24333575
13.

Intestinal inflammation in a murine model of autism spectrum disorders.

de Theije CG, Koelink PJ, Korte-Bouws GA, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD.

Brain Behav Immun. 2014 Mar;37:240-7. doi: 10.1016/j.bbi.2013.12.004. Epub 2013 Dec 7.

PMID:
24321212
14.

Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression.

Borre YE, Panagaki T, Koelink PJ, Morgan ME, Hendriksen H, Garssen J, Kraneveld AD, Olivier B, Oosting RS.

Neuropharmacology. 2014 Apr;79:738-49. doi: 10.1016/j.neuropharm.2013.11.009. Epub 2013 Nov 25.

PMID:
24286859
15.

New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation.

Morgan ME, Zheng B, Koelink PJ, van de Kant HJ, Haazen LC, van Roest M, Garssen J, Folkerts G, Kraneveld AD.

PLoS One. 2013 Jul 25;8(7):e69936. doi: 10.1371/journal.pone.0069936. Print 2013.

16.

Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease.

Koelink PJ, Overbeek SA, Braber S, Morgan ME, Henricks PA, Abdul Roda M, Verspaget HW, Wolfkamp SC, te Velde AA, Jones CW, Jackson PL, Blalock JE, Sparidans RW, Kruijtzer JA, Garssen J, Folkerts G, Kraneveld AD.

Gut. 2014 Apr;63(4):578-87. doi: 10.1136/gutjnl-2012-303252. Epub 2013 Mar 23.

17.

Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?

Overbeek SA, Braber S, Koelink PJ, Henricks PA, Mortaz E, LoTam Loi AT, Jackson PL, Garssen J, Wagenaar GT, Timens W, Koenderman L, Blalock JE, Kraneveld AD, Folkerts G.

PLoS One. 2013;8(1):e55612. doi: 10.1371/journal.pone.0055612. Epub 2013 Jan 31. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/0faf4c12-4fd4-474c-b5a4-16e49370aff3.

18.

Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts.

Hawinkels LJ, Paauwe M, Verspaget HW, Wiercinska E, van der Zon JM, van der Ploeg K, Koelink PJ, Lindeman JH, Mesker W, ten Dijke P, Sier CF.

Oncogene. 2014 Jan 2;33(1):97-107. doi: 10.1038/onc.2012.536. Epub 2012 Dec 3.

PMID:
23208491
19.

An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease.

Braber S, Thio M, Blokhuis BR, Henricks PA, Koelink PJ, Groot Kormelink T, Bezemer GF, Kerstjens HA, Postma DS, Garssen J, Kraneveld AD, Redegeld FA, Folkerts G.

Am J Respir Crit Care Med. 2012 Apr 15;185(8):817-24. doi: 10.1164/rccm.201104-0761OC. Epub 2012 Jan 6.

PMID:
22227380
20.

5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.

Baan B, Dihal AA, Hoff E, Bos CL, Voorneveld PW, Koelink PJ, Wildenberg ME, Muncan V, Heijmans J, Verspaget HW, Richel DJ, Hardwick JC, Hommes DW, Peppelenbosch MP, van den Brink GR.

Gut. 2012 Dec;61(12):1708-15. doi: 10.1136/gutjnl-2011-301626. Epub 2011 Dec 20.

PMID:
22187071
21.

Targeting chemokine receptors in chronic inflammatory diseases: an extensive review.

Koelink PJ, Overbeek SA, Braber S, de Kruijf P, Folkerts G, Smit MJ, Kraneveld AD.

Pharmacol Ther. 2012 Jan;133(1):1-18. doi: 10.1016/j.pharmthera.2011.06.008. Epub 2011 Aug 1. Review.

PMID:
21839114
22.

CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.

Braber S, Overbeek SA, Koelink PJ, Henricks PA, Zaman GJ, Garssen J, Kraneveld AD, Folkerts G.

Eur J Pharmacol. 2011 Oct 15;668(3):443-9. doi: 10.1016/j.ejphar.2011.03.025. Epub 2011 Mar 31.

PMID:
21458445
23.

N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 release.

Overbeek SA, Henricks PA, Srienc AI, Koelink PJ, de Kruijf P, Lim HD, Smit MJ, Zaman GJ, Garssen J, Nijkamp FP, Kraneveld AD, Folkerts G.

Eur J Pharmacol. 2011 Oct 15;668(3):428-34. doi: 10.1016/j.ejphar.2011.03.022. Epub 2011 Mar 31.

24.

Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown.

Braber S, Koelink PJ, Henricks PA, Jackson PL, Nijkamp FP, Garssen J, Kraneveld AD, Blalock JE, Folkerts G.

Am J Physiol Lung Cell Mol Physiol. 2011 Feb;300(2):L255-65. doi: 10.1152/ajplung.00304.2010. Epub 2010 Nov 26.

25.

A new conditional Apc-mutant mouse model for colorectal cancer.

Robanus-Maandag EC, Koelink PJ, Breukel C, Salvatori DC, Jagmohan-Changur SC, Bosch CA, Verspaget HW, Devilee P, Fodde R, Smits R.

Carcinogenesis. 2010 May;31(5):946-52. doi: 10.1093/carcin/bgq046. Epub 2010 Feb 22.

PMID:
20176656
26.

5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.

Koelink PJ, Mieremet-Ooms MA, Corver WE, Wolanin K, Hommes DW, Lamers CB, Verspaget HW.

Inflamm Bowel Dis. 2010 Mar;16(3):379-89. doi: 10.1002/ibd.21086.

PMID:
19774649
27.

Clinical significance of stromal apoptosis in colorectal cancer.

Koelink PJ, Sier CF, Hommes DW, Lamers CB, Verspaget HW.

Br J Cancer. 2009 Sep 1;101(5):765-73. doi: 10.1038/sj.bjc.6605220. Epub 2009 Aug 4.

28.

5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.

Koelink PJ, Hawinkels LJ, Wiercinska E, Sier CF, ten Dijke P, Lamers CB, Hommes DW, Verspaget HW.

Cancer Lett. 2010 Jan 1;287(1):82-90. doi: 10.1016/j.canlet.2009.05.033. Epub 2009 Jun 21.

PMID:
19541409
29.

5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.

Koelink PJ, Robanus-Maandag EC, Devilee P, Hommes DW, Lamers CB, Verspaget HW.

Carcinogenesis. 2009 Jul;30(7):1217-24. doi: 10.1093/carcin/bgp113. Epub 2009 May 6.

PMID:
19420017
30.

Circulating cell death products predict clinical outcome of colorectal cancer patients.

Koelink PJ, Lamers CB, Hommes DW, Verspaget HW.

BMC Cancer. 2009 Mar 23;9:88. doi: 10.1186/1471-2407-9-88.

31.

Identification of a luteinizing hormone-selective determinant in the exodomain of a follicle-stimulating hormone receptor.

Vischer HF, Granneman JC, Koelink PJ, Marques RB, Bogerd J.

Gen Comp Endocrinol. 2008 May 1;156(3):490-8. doi: 10.1016/j.ygcen.2008.03.017. Epub 2008 Mar 25.

PMID:
18433752
32.

5-ASA and colorectal cell-cycle progression.

Koelink PJ, Verspaget HW.

Gastroenterology. 2007 Apr;132(4):1635-6; author reply 1636. No abstract available.

PMID:
17418160

Supplemental Content

Loading ...
Support Center